z-logo
open-access-imgOpen Access
Repressive Effect of Primary Virus Replication on Superinfection Correlated with Gut-Derived Central Memory CD4+ T Cells in SHIV-Infected Chinese Rhesus Macaques
Author(s) -
Jing Xue,
Zhe Cong,
Jing Xiong,
Wei Wang,
Hong Jiang,
Ting Chen,
Fang-xin Wu,
Kejian Liu,
Aihua Su,
Bin Ju,
Zhiwei Chen,
Marcelo Couto,
Qiang Wang,
Chuan Qin
Publication year - 2013
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0072295
Subject(s) - superinfection , biology , viremia , virology , viral replication , virus , immunology
A possible mechanism of susceptibility to superinfection with simian-human immunodeficiency virus (SHIV)-1157ipd3N4 was explored in twelve SHIV SF162P3 -infected Chinese rhesus macaques. Based on the kinetics of viral replication for the second infecting virus following SHIV-1157ipd3N4 inoculation, the monkeys were divided into two groups: those relatively resistant to superinfection (SIR) and those relatively sensitive to superinfection (SIS). We found that superinfection-resistant macaques had high primary viremia, whereas superinfection-sensitive macaques had low primary viremia, suggesting that primary SHIV SF162P3 infection with a high viral-replication level would repress superinfection with a heterologous SHIV-1157ipd3N4. Although no correlation of protection against superinfection with virus-specific CD4 + T cell or CD8 + T cell immune responses from gut was observed prior to superinfection, superinfection susceptibility was strongly correlated with CD4 + Tcm cells from gut both prior to the second infecting virus inoculation and on day 7 after superinfection, but not with CD4 + Tem cells from gut or with CD4 + Tcm cells from peripheral blood and lymph node. These results point to the important roles of gut-derived CD4 + Tcm cells for the study of the mechanisms of protection against superinfection and the evaluation of the safety and efficacy of vaccines and therapies against acquired immune deficiency syndrome (AIDS).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here